跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BILASTINA KERN PHARMA 20 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BILASTINA KERN PHARMA 20 MG COMPRIMIDOS EFG
Approved
STANDARD
BILASTINA KERN PHARMA 20 MG COMPRIMIDOS EFG
Kern Pharma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 7, 2021
Approval ID
7059c4778c23a02a
Company
Kern Pharma S.L.
Type
Standard
Approval Details
Approval Id
7059c4778c23a02a
Drug Cima Aemps Name
BILASTINA KERN PHARMA 20 MG COMPRIMIDOS EFG
Register Number
85898
Holder Company Name
Kern Pharma S.L.
Marketing Company Name
Kern Pharma S.L.
Holder Company Detail Path
/organization/kern-pharma-s-l
Marketing Company Detail Path
/organization/kern-pharma-s-l
Authorization Date
2021-04-07
Dosage Form
COMPRIMIDO
Dose
20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Kern Pharma S.L.
Company Detail Path
/organization/kern-pharma-s-l
Company Information
Pharmaceutical Company Name
Kern Pharma S.L.
Country Name
Dominican Republic
Active Ingredients
BILASTINA
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 7, 2021
Approval ID
7059c4778c23a02a
Type
Standard
Back to CIMA-AEMPS Approvals
